Primary Sclerosing Cholangitis clinical trials at UC Davis
1 research study open to eligible people
A Study of Experimental Sulfasalazine for Primary Sclerosing Cholangitis (inflammation and scarring of the bile ducts)
“This research study hopes to find out if experimental treatment with sulfasalazine can help people with PSC.”
open to eligible people ages 15-80
This is a multicenter, randomized, double-blinded placebo controlled trial to assess the benefit of sulfasalazine in the treatment of PSC. The specific objectives of this study are to determine if sulfasalazine treatment 1) results in reduced serum ALP and other biomarkers of liver injury in PSC; 2) improves PSC patient symptoms; and 3) is safe in patients with PSC.
Davis, California and other locations